Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E
Metabolites. 2025; 15(2).
PMID: 39997751
PMC: 11857149.
DOI: 10.3390/metabo15020127.
Linder L
Integr Med (Encinitas). 2025; 24(1):26-30.
PMID: 39896831
PMC: 11778319.
Salari N, Ahmadi M, Ghasemi H, Yarani R, Mohammadi M
Iran J Public Health. 2024; 53(9):2020-2029.
PMID: 39429667
PMC: 11490326.
DOI: 10.18502/ijph.v53i9.16455.
Ghanbari F, Hasani S, Aghili Z, Asgary S
Food Sci Nutr. 2024; 12(7):4569-4580.
PMID: 39055176
PMC: 11266939.
DOI: 10.1002/fsn3.4142.
Cao K, Tao M, Pu X, Hou Y, Ren Y, Liu W
Ecol Evol. 2024; 14(6):e11507.
PMID: 38932956
PMC: 11199130.
DOI: 10.1002/ece3.11507.
Natural products for managing metabolic syndrome: a scoping review.
Abdulghani M, Al-Fayyadh S
Front Pharmacol. 2024; 15:1366946.
PMID: 38746011
PMC: 11091304.
DOI: 10.3389/fphar.2024.1366946.
Metabolic Status Influences Probiotic Efficacy for Depression-PRO-DEMET Randomized Clinical Trial Results.
Gawlik-Kotelnicka O, Margulska A, Pleska K, Skowronska A, Strzelecki D
Nutrients. 2024; 16(9).
PMID: 38732635
PMC: 11085729.
DOI: 10.3390/nu16091389.
Accounting for the health risk of probiotics.
Liu X, Zhao H, Wong A
Heliyon. 2024; 10(6):e27908.
PMID: 38510031
PMC: 10950733.
DOI: 10.1016/j.heliyon.2024.e27908.
Nutritional Approaches Targeting Gut Microbiota in Oxidative-Stress-Associated Metabolic Syndrome: Focus on Early Life Programming.
Tain Y, Hsu C
Nutrients. 2024; 16(5).
PMID: 38474810
PMC: 10935367.
DOI: 10.3390/nu16050683.
The effects of powdered drinks enriched with curcumin and probiotics on lipid profile and atherogenic indices in patients with metabolic syndrome: A randomized, double-blinded, placebo-controlled clinical trial.
Mohammadi F, Mohsenpour M, Sohrabi Z, Niakousari M, Jeddi M, Hassanzadeh J
Food Sci Nutr. 2024; 12(2):1257-1267.
PMID: 38370069
PMC: 10867475.
DOI: 10.1002/fsn3.3839.
The supplementation of the multi-strain probiotics WHHPRO™ alleviates high-fat diet-induced metabolic symptoms in rats via gut-liver axis.
Chen C, Gao K, Chen Z, Zhang Q, Ke X, Mao B
Front Nutr. 2024; 10:1324691.
PMID: 38274203
PMC: 10808617.
DOI: 10.3389/fnut.2023.1324691.
NF-kB Regulation and the Chaperone System Mediate Restorative Effects of the Probiotic LF31 in the Small Intestine and Cerebellum of Mice with Ethanol-Induced Damage.
Paladino L, Rappa F, Barone R, Macaluso F, Zummo F, David S
Biology (Basel). 2023; 12(11).
PMID: 37997993
PMC: 10669058.
DOI: 10.3390/biology12111394.
Investigating the Efficacy of in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far.
Egea M, de Oliveira Filho J, Lemes A
Int J Mol Sci. 2023; 24(15).
PMID: 37569390
PMC: 10418856.
DOI: 10.3390/ijms241512015.
Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review.
Sadagopan A, Mahmoud A, Begg M, Tarhuni M, Fotso M, Gonzalez N
Cureus. 2023; 15(7):e41559.
PMID: 37554593
PMC: 10405753.
DOI: 10.7759/cureus.41559.
Evaluation of Subsp (Canan SV-53) as a Potential Probiotic Bacterium.
Novotny-Nunez I, Perdigon G, Matar C, Martinez Monteros M, Yahfoufi N, Cazorla S
Microorganisms. 2023; 11(5).
PMID: 37317321
PMC: 10220916.
DOI: 10.3390/microorganisms11051347.
Influence of on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial.
Chaiyasut C, Sivamaruthi B, Lailerd N, Sirilun S, Thangaleela S, Khongtan S
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242478
PMC: 10220806.
DOI: 10.3390/ph16050695.
Antiobesity Effect of LM-141 on High-Fat Diet-Induced Rats through Alleviation of Inflammation and Insulin Resistance.
Wu C, Lin C, Hsieh F, Wu T, Fang A
Evid Based Complement Alternat Med. 2023; 2023:1011591.
PMID: 37114144
PMC: 10129431.
DOI: 10.1155/2023/1011591.
PRO-DEMET Randomized Controlled Trial on Probiotics in Depression-Pilot Study Results.
Gawlik-Kotelnicka O, Margulska A, Skowronska A, Strzelecki D
Nutrients. 2023; 15(6).
PMID: 36986132
PMC: 10058314.
DOI: 10.3390/nu15061400.
Intake of Low Glycaemic Index Foods but Not Probiotics Is Associated with Atherosclerosis Risk in Women with Polycystic Ovary Syndrome.
Bykowska-Derda A, Kaluzna M, Garbacz A, Ziemnicka K, Ruchala M, Czlapka-Matyasik M
Life (Basel). 2023; 13(3).
PMID: 36983954
PMC: 10052525.
DOI: 10.3390/life13030799.
Assessment of Lab4P Probiotic Effects on Cognition in 3xTg-AD Alzheimer's Disease Model Mice and the SH-SY5Y Neuronal Cell Line.
Webberley T, Bevan R, Kerry-Smith J, Dally J, Michael D, Thomas S
Int J Mol Sci. 2023; 24(5).
PMID: 36902113
PMC: 10003662.
DOI: 10.3390/ijms24054683.